Lenalidomide therapy in patients with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)

Am J Hematol. 2018 Jan;93(1):E27-E30. doi: 10.1002/ajh.24952. Epub 2017 Nov 10.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Anemia, Sideroblastic / complications
  • Humans
  • Lenalidomide / therapeutic use*
  • Myelodysplastic-Myeloproliferative Diseases / complications*
  • Myelodysplastic-Myeloproliferative Diseases / drug therapy*
  • Thrombocytosis / complications

Substances

  • Lenalidomide